EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC 4.0

Elevated amputation rates in COVID ‐19 survivors: Insights from a large‐scale Japanese cohort study

Daisuke Miyamori iD, Shuhei Yoshida, Masanori Ito

Journal of Diabetes Investigation · 2025

DOI: 10.1111/jdi.70078 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of Diabetes Investigation, 2025. Verfasst von Daisuke Miyamori und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Internal Medicine, Hiroshima University Hospital, Hiroshima, Japan. Hauptthemen laut MEDLINE: COVID-19, Amputation, Surgical. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Innovative Research Program on Suicide Countermeasures, Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

COVID‐19 has been linked to increased vascular complications, but its long‐term impact on amputation rates is unclear. This study evaluated amputation risk post‐COVID‐19 using a nationwide insurance claims database in Japan.

Methods

We conducted a retrospective cohort study using data from the National Database of Health Insurance Claims and Specific Health Checkups of Japan. COVID‐19 cases were identified via insurance payment waivers, and amputations were defined by procedure codes. Propensity score matching created balanced cohorts of COVID‐19 exposed and unexposed individuals. Matched cohorts were compared for amputation incidence, calculating incidence rate ratios (IRRs), and differences (IRDs). Sensitivity analyses examined outcomes at different time points, and subgroup analyses stratified results by key characteristics.

Results

This study included 3,098,948 matched pairs. Over a median follow‐up of 7 months, 286 amputations occurred in the COVID‐19 group vs 123 in controls (IRR 2.33, 95% CI 1.88–2.90; IRD 5.57 per 1,000,000 person‐months, 95% CI 4.22–6.92). The elevated risk persisted beyond 2 years post infection (IRR 2.03, 95% CI 1.31–3.20). Subgroup analyses showed higher risks in individuals with higher comorbidity burden (Charlson Comorbidity Index [CCI] ≥2; IRR 2.45 95% CI 1.92, 2.79) vs lower comorbidity burden (CCI 0–1; IRR 0.71 95%CI 0.29, 1.71) with significant interaction ( P = 0.04).

Conclusions

Amputation rates increased among COVID‐19 survivors, persisting for over 2 years post infection. The interaction between COVID‐19 and comorbidity burden highlights the need for vigilant long‐term monitoring and management of vascular complications in COVID‐19 survivors, particularly those with multiple comorbidities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Amputation, SurgicalHumansMaleFemaleMiddle AgedRetrospective StudiesJapanAgedSARS-CoV-2AdultIncidenceSurvivorsRisk FactorsEast Asian People

Stichwörter der Autor:innen

AmputationCOVID‐19National Insurance Claims Database

Autor:innen und Institutionen

  • Department of General Internal Medicine, Hiroshima University Hospital, Hiroshima, Japan.

ORCID-Profile: Daisuke Miyamori

Förderung

  • Innovative Research Program on Suicide Countermeasures
  • Japan Society for the Promotion of Science

Zitieren

APA

Miyamori, D., Yoshida, S., & Ito, M. (2025). Elevated amputation rates in COVID ‐19 survivors: Insights from a large‐scale Japanese cohort study. Journal of Diabetes Investigation. https://doi.org/10.1111/jdi.70078

Vancouver

Miyamori D, Yoshida S, Ito M. Elevated amputation rates in COVID ‐19 survivors: Insights from a large‐scale Japanese cohort study. Journal of Diabetes Investigation. 2025. doi:10.1111/jdi.70078

BibTeX
@article{Miyamori2025,
  author = {Miyamori, Daisuke and Yoshida, Shuhei and Ito, Masanori},
  title = {Elevated amputation rates in COVID ‐19 survivors: Insights from a large‐scale Japanese cohort study},
  journal = {Journal of Diabetes Investigation},
  year = {2025},
  doi = {10.1111/jdi.70078}
}
Kostenlos starten →